Eucrates Biomedical Acquisition Corp.
EUCR · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|
| Assets | – | – | – |
| Cash & Equivalents | $19 | $49 | $551 |
| Short-Term Investments | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $215 | $0 |
| Total Curr. Assets | $132 | $264 | $1,021 |
| Property Plant & Equip (Net) | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 |
| Other NC Assets | $12,353 | $104,843 | $104,806 |
| Total NC Assets | $12,353 | $104,843 | $104,806 |
| Other Assets | $0 | $0 | $0 |
| Total Assets | $12,485 | $105,107 | $105,827 |
| Liabilities | – | – | – |
| Payables | $0 | $0 | $0 |
| Short-Term Debt | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 |
| Other Curr. Liab. | $65 | $0 | $0 |
| Total Curr. Liab. | $65 | $38 | $53 |
| LT Debt | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 |
| Other NC Liab. | $3,885 | $0 | $0 |
| Total NC Liab. | $3,885 | $5,762 | $3,668 |
| Other Liabilities | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 |
| Total Liabilities | $3,950 | $5,800 | $3,720 |
| Equity | – | – | – |
| Pref Stock | $0 | $0 | $0 |
| Common Stock | $12,253 | $104,796 | $102,248 |
| Retained Earnings | -$3,718 | -$5,490 | -$142 |
| AOCI | $0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 |
| Total Equity | $8,536 | $99,307 | $102,106 |
| Supplemental Information | – | – | – |
| Minority Interest | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $12,485 | $105,107 | $105,827 |
| Net Debt | -$19 | -$49 | -$551 |